ACG Worldwide, India and KORSCH AG, Germany has announced their joint venture (JV) to develop and produce tablet compression systems in India on the sidelines of the CPhI/P-MEC/ICSE India 2009 exhibition. The JV will expand the global footprints of both companies and will benefit from the established worldwide sales channels and offices of both partners.
CPhI/P-MEC/ICSE India 2009, South Asia’s premier pharmaceutical event organised by United Business Media (UBM) saw several major pharmaceutical companies announcing their expansion plans. The exhibition and conference brought together the who's who of the pharmaceutical industry, and acted as a catalyst for the exchange of expertise, technical know-how, and innovations.
Foreseeing the bright future for the Indian Pharma industry, SMEs have begun expanding their horizons. Mumbai-based pharmaceutical company Schott Kaisha announced its plans to set up a greenfield facility in Baroda with an approximate investment of Rs 50 crore by the next financial year end. The company will fund the project though internal accruals and partially through debt activity.
GMP Technical Solutions announced its plans to set up a new GRP clean room facility in Himachal Pradesh to serve pharma and biotech industries. The company will be the first in India and second in the world to offer this service, following the UK- based company MRC.
The hugely successful three-day event at the Bombay Exhibition Centre, Mumbai, had over 770 exhibitors from 20 countries and visitors from 63 countries.
CPhI India and the co-located P-MEC and ICSE are the leading exhibitions for pharmaceutical ingredients and allied industries. P-MEC is the largest exhibition for the pharmaceutical machinery and equipment industry in India. ICSE is India’s fastest growing show for the burgeoning outsourcing and contract services sector. This year’s event has seen the introduction of the biosimilars conference, which gave delegates an insight into India’s biosimilars regulatory framework, cost -effective global sourcing strategies for biosimilar ingredients, materials and services.
To take this theme further, CPhI/P-MEC/ICSE India 2009 also had the curtain raiser at the India Pharma Summit. Organized by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt of India in partnership with UBM and Ficci, the conference was attended by experts from the pharma industry. The summit identified opportunities, challenges and created a roadmap to achieve consistent growth. The summit covered topics like “India Pharma - Status and Opportunities for Production, Investment & Trade,” Opportunities and Challenges in R&D, Clinical Trials, Pharma Education and Industry Academia Partnership” and Vision – “India the Global Partner.”
CPhI/P-MEC/ICSE India 2009 and the Biosimilars conference was attended by decision makers and executives from the chemical and pharmaceutical industry. Small & Medium Enterprises(SMEs) from the industry participated in big numbers.The event was an ideal platform for SMEs to network, interact, and highlight their achievements to the global pharma industry and to initiate global partnerships.
CPhI/P-MEC/ICSE India was staged once again in the Mumbai Exhibition Centre, from December 1 to 3 in 2010.